Bristol-Myers Squibb is having a busy holiday period, signing a $4.1 billion deal to acquire cancer drug developer RayzeBio – its second multibillion-dollar M&A deal in the space of a week. BMS is ...

Bristol-Myers Squibb's has become the first company to bring a cardiac myosin inhibitor through to FDA approval, claiming a green light from the US regulator for mavacamten as a therapy for ...

Upgrade your eyewear with glasses that can function as cameras, headphones, and AR displays. We've tested all the major models and have everything you need to know to pick the right smart glasses for ...

I started with CNET reviewing laptops in 2009. Now I explore wearable tech, VR/AR, tablets, gaming and future/emerging trends in our changing world. Other obsessions include magic, immersive theater, ...

The artwork was installed under the cloak of night this week, less than two months after a journalism investigation into Banksy’s true identity was published On a state visit to the United States this ...

The impending merger between Bristol-Myers Squibb (BMS) and Medarex marks the end of an era. Medarex is one of the last independent public biotech companies that built their businesses around ...

Stream the latest Hit it Hard videos on Watch ESPN. If professional golf were put to country music, then the song would be about John Daly. This film covers Daly’s rise and fall, and his struggles ...